Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 018893
Company: HOSPIRA
Company: HOSPIRA
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
SODIUM ACETATE | SODIUM ACETATE | 40MEQ/20ML (2MEQ/ML) | SOLUTION;INTRAVENOUS | Prescription | AP | Yes | Yes |
SODIUM ACETATE | SODIUM ACETATE | 100MEQ/50ML (2MEQ/ML) | SOLUTION;INTRAVENOUS | Prescription | AP | Yes | Yes |
SODIUM ACETATE | SODIUM ACETATE | 200MEQ/100ML (2MEQ/ML) | SOLUTION;INTRAVENOUS | Prescription | AP | Yes | Yes |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
09/02/2014 | SUPPL-25 | Manufacturing (CMC) | Label (PDF) | This supplement type does not usually require new labeling. | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/018893s025lbl.pdf |